CXXC5 and metabolic dysfunction-associated steatohepatitis: As an approach to abolish CXXC5 function and determine its role in the pathological phenotypes of NASH, we examined the effects of KY19334, a small molecule that activates the Wnt/β-catenin pathway by inhibiting its interaction with Dvl24.